Ecovia Bio
PrivateLast Round
Series B
Feb 3, 2026
Total Funding Raised
$1.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ecovia Bio operates in Energy & Sustainability and is based in Livonia, Michigan. Its latest recorded funding round was a Series B round in February 2026.
Ecovia Bio is a biotechnology company that develops and commercializes sustainable, high-performance biopolymers derived from fermentation processes for the cosmetics, personal care, and agriculture industries.
Sector
Energy & Sustainability
Verticals
Biotechnology, Advanced Materials, Sustainable Materials, Circular Economy, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ecovia Bio Comparables
Compare Ecovia Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanjing Shineking Biotech Co., Ltd. | 83% | |
| Polygreen Group | 82% | |
| ZymoChem | 79% |
For institutional investors. Book with your work email.
Ecovia Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 3, 2026 | ||||
| Early Funding | Dec 10, 2024 | ||||
| Early Funding | Aug 15, 2023 | ||||
| Early Funding | Mar 17, 2023 | ||||
| Seed | Oct 3, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ecovia Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pointe Angels | Series B |
| Accelerate Blue Fund | Series B |
| Pointe Angels | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Led by Pointe Angels with participation from Accelerate Blue Fund.
- Mar 27, 2025
Monthly visitors grew 40% MoM.
For institutional investors. Book with your work email.
Ecovia Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ecovia Bio's valuation, stock price, and market status.
Is Ecovia Bio a public or private company?
Ecovia Bio is a private company.
What is the current stock price of Ecovia Bio?
Ecovia Bio is a private company, so its shares have no public market price. Caplight tracks Ecovia Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ecovia Bio worth (valuation)?
Valuation information for Ecovia Bio is not publicly available.
Can I buy Ecovia Bio stock?
Ecovia Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ecovia Bio's last funding round?
Ecovia Bio's most recent funding round was Series B on February 3, 2026.
Who are the main investors in Ecovia Bio?
Key investors in Ecovia Bio include Pointe Angels, Pointe Angels.
Will Ecovia Bio IPO soon?
No public IPO plans have been announced for Ecovia Bio.
How can I track Ecovia Bio secondary market activity?
Caplight tracks bids, offers, and trades in Ecovia Bio's shares on secondary markets.